DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label trans-3-hydroxy- cyclobutanecarboxylic acid methyl ester. Show all posts
Showing posts with label trans-3-hydroxy- cyclobutanecarboxylic acid methyl ester. Show all posts

Thursday 16 July 2015

trans-3-hydroxy- cyclobutanecarboxylic acid methyl ester

trans-3-hydroxy- cyclobutanecarboxylic acid methyl ester

Example 47
Preparation of amines (for Example 16 and 43) and alcohols (for Example 7 and 9)
Example 47-1 : 4-Hydroxy-2,2-dimethylbutyric acid ethyl ester

A mixture of dιhydro-3,3-dιmethyl-2(3/-/)-furanone (10 mmol, 1 14 g), aqueous 1 M KOH solution (10 mmol) and one drop of phenolphthalem indicator (0 5% w/v in EtOH/water (1 1)) is stirred at 105 0C for 3 5 hours The mixture is cooled to ambient temperature and concentration under reduced pressure To the residue is added 10 ml_ of EtOH To the solution is added 50 ml of Et2O and the solid isolated by filtration and dried under 100 mbar at 50 0C to give potassium 4-hydroxy-2,2-dιmethylbutyrate (1 21 g, 71 %) 1H NMR (400 MHz, c/5 DMSO) δ ppm 0 96 (s, 6 H), 1 47 (t, J = 5 54 Hz, 2 H), 3 43 (t, J = 5 54 Hz, 2 H)
To a solution of potassium 4-hydroxy-2,2-dιmethylbutyrate (1 92 mmol, 327 mg) in DMF (6 ml_) is added ethyl iodide (2 30 mmol, 359 mg) The reaction mixture is stirred for 2 hours, and quenched with saturated ammonium chloride solution The product is extracted three times with EtOAc The combined organic layer is washed with aqueous 0 1 M HCI then brine, dried over Na2SO4, filtered, concentrated under reduced pressure to give 4-Hydroxy-2,2- dimethylbutyπc acid ethyl ester (520 mg) contaminated with DMF
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1 22 (s, 6 H) 1 26 (t, J = 7 06 Hz, 3 H) 1 82- 1 85 (m, 2 H) 1 91 (brs, 1 H) 3 69 (t, J = 6 55 Hz, 2 H) 4 13 (q, J = 7 06 Hz, 2 H) Example 47-2: fraπs-3-hydroxy-cyclobutanecarboxylic acid methyl ester

To a solution of cis-trans mixture of 3-hydroxy-cyclobutanecarboxylic acid methyl ester (1 .30 g, 10 mmol) in DMF 13 mL is added NaH (50% in oil, 720 mg, 15 mmol) at 0 0C. After stirring at 0 0C for 15 minutes, benzyl bromide (1.43 ml, 12 mmol) is added at 0 0C. The mixture is stirred at room temperature for 2 hours and quenched with H2O. The solution is extracted with EtOAc. The organic layer is washed with H2O and brine, dried over MgSO4 and concentrated under reduced pressure. The residue is purified by silica gel column chromatography (eluent; hexane / EtOAc) to give trans-3-benzyloxy-cyclobutanecarboxylic acid methyl ester (340 mg, 15.4%). TLC (hexane/EtOAc, 5:1 ) Rf 0.40. 1 H NMR (400 MHz, chloroform-d) δ ppm 2.26-2.34 (m, 2H), 2.48-2.52 (m, 2H), 3.02-3.06 (m, 1 H), 3.69 (s, 3H), 4.26-4.33 (m, 1 H), 4.42 (s, 2H)1 7.27-7.35 (m, 5H).
A solution of frans-3-benzyloxy-cyclobutanecarboxylic acid methyl ester (680 mg, 3.09 mmol) as 0.05 M solution in MeOH is pumped through the H-Cube™ flow hydrogenator fitted with a 10 mol% Pd/C catalyst cartridge heated to 40 0C at 10 bar. The flow rate is set at 1 ml/min. The solvent is removed under reduced pressure to give trans-3-hydroxy- cyclobutanecarboxylic acid methyl ester (380 mg, 94.5%); TLC (hexane/EtOAc, 1 :1 ) Rf 0.38. 1 H NMR (400 MHz, chloroform-d) δ ppm 2.18-2.25 (m, 2H), 2.55-2.61 (m, 2H), 3.01-3.08 (m, 1 H), 3.70 (s, 3H)1 4.53-4.61 (m, 1 H).


 http://www.google.com/patents/WO2009071509A1?cl=en










सुकून उतना ही देना प्रभू, जितने से जिंदगी चल जाये।औकात बस इतनी देना,कि औरों का भला हो जाये।...........
P.S. : The views expressed are my personal and in no-way suggest the views of the professional 
body or the company that I represent.

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE
Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

 amcrasto@gmail.com

09b37-misc2b027LIONEL MY SON
He was only in first standard in school when I was hit by a deadly one in a million spine stroke called acute transverse mylitis, it made me 90% paralysed and bound to a wheel chair, Now I keep him as my source of inspiration and helping millions, thanks to millions of my readers who keep me going and help me to keep my son happy